FAQ published on June 14, 2013
Dr. James Armitage discusses the current standard optimal chemotherapy regimen for patients with Hodgkin lymphoma.
Page 7 of 7
Results 61 - 61 of 61

Managing HL would like to recognize and thank Merck & Co., Inc., Seattle Genetics, and Takeda Oncology for their educational support of ManagingHodgkinLymphoma.com

©2018 MediCom Worldwide, Inc. All rights reserved